Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acer Therapeutics Inc (ACER)

Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,149
  • Shares Outstanding, K 24,464
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,240 K
  • 60-Month Beta 0.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ACER with:
  • Price/Earnings ttm 3.66
  • Earnings Per Share ttm 0.22
  • Most Recent Earnings $-0.53 on 11/20/23
  • Next Earnings Date 05/20/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6000 +10.02%
on 11/09/23
0.9200 -28.25%
on 11/08/23
-0.1670 (-20.19%)
since 10/20/23
3-Month
0.5515 +19.69%
on 08/25/23
1.7599 -62.49%
on 08/31/23
-0.0669 (-9.20%)
since 08/18/23
52-Week
0.5515 +19.69%
on 08/25/23
4.5600 -85.52%
on 12/23/22
-0.5199 (-44.06%)
since 11/18/22

Most Recent Stories

More News
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

TWNK : 33.30 (-0.15%)
LVOX : 3.73 (+0.81%)
ACER : 0.6601 (-17.95%)
PNT : 12.50 (+0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, HT, ABCM, ACER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
HT : 9.99 (-0.10%)
ABCM : 23.99 (+0.04%)
ACER : 0.6601 (-17.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ABCM : 23.99 (+0.04%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
NXGN : 23.94 (+0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WRK, AGE, ACER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WRK : 52.49 (-0.85%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

THRN : 10.19 (-0.10%)
ABCM : 23.99 (+0.04%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra

/PRNewswire/ -- Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with...

ACER : 0.6601 (-17.95%)
Acer Therapeutics Inc. (ACER) Gains But Lags Market: What You Should Know

Acer Therapeutics Inc. (ACER) closed at $0.76 in the latest trading session, marking a +1.13% move from the prior day.

ACER : 0.6601 (-17.95%)
ACER's Stock Down on Failure of Phase II Study, Cash Updates

ACER announces the failure of its phase IIa study of ACER-801 to treat vasomotor symptoms associated with menopause, along with its extinguishing cash runway. Stock down.

SNY : 48.42 (-0.51%)
ACER : 0.6601 (-17.95%)
AZYO : 1.4900 (+2.05%)
AVTX : 11.10 (+15.75%)
Acer Therapeutics Inc. (ACER) Dips More Than Broader Markets: What You Should Know

Acer Therapeutics Inc. (ACER) closed the most recent trading day at $1.67, moving -1.76% from the previous trading session.

ACER : 0.6601 (-17.95%)
Acer Therapeutics Inc. (ACER) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Acer Therapeutics Inc. (ACER) closed at $2.16, marking a -0.92% move from the previous day.

ACER : 0.6601 (-17.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics,...

See More

Key Turning Points

3rd Resistance Point 0.9766
2nd Resistance Point 0.9133
1st Resistance Point 0.7867
Last Price 0.6601
1st Support Level 0.5968
2nd Support Level 0.5335
3rd Support Level 0.4069

See More

52-Week High 4.5600
Fibonacci 61.8% 3.0288
Fibonacci 50% 2.5557
Fibonacci 38.2% 2.0827
Last Price 0.6601
52-Week Low 0.5515

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar